Anchor My Faith

Learn more

Section 7.1 Laboratory

Laboratory Report #15

Date

Collection Date: December 15, 2021
Report Date: December 16, 2021

Laboratory

Labcorp

Ordering Physician

Dr. Rihab Kheir

Report Type

Rheumatology Follow-up Evaluation

Laboratory testing included:

  • Complete Blood Count (CBC) with Differential
  • Complete Urinalysis with Microscopic Examination
  • Iron and Total Iron-Binding Capacity (TIBC)
  • Ferritin
  • Complement C3 and C4
  • Anti-double-stranded DNA (Anti-dsDNA) Antibodies
  • Erythrocyte Sedimentation Rate (ESR)
  • C-Reactive Protein (CRP)

Original Report

PDF: Labcorp – December 15, 2021

One-Page Summary

Purpose of Testing

This laboratory evaluation was performed as a rheumatology follow-up approximately two months after the peak inflammatory phase of your systemic inflammatory illness. The primary objectives were to assess the degree of ongoing inflammation, evaluate recovery from inflammatory anemia, investigate autoimmune activity, assess iron status, and monitor kidney involvement through urinalysis. Compared with the October 2021 studies, this report demonstrates substantial clinical improvement and marks the beginning of laboratory recovery.

Major Findings

Inflammatory Markers

Erythrocyte Sedimentation Rate (ESR)

Result

  • 15 mm/hr (Normal)

C-Reactive Protein (CRP)

Result

  • 2 mg/L (Normal)

Interpretation

This report documents a remarkable improvement in systemic inflammation.

Compared with the October 2021 evaluation:

  • ESR decreased from 73 → 15 mm/hr
  • CRP decreased from 35 → 2 mg/L

Both markers returned to normal laboratory ranges, providing objective evidence that the inflammatory process had substantially resolved.

Complete Blood Count

Results

  • WBC: 5.7 ×10³/µL
  • RBC: 4.25 ×10⁶/µL
  • Hemoglobin: 12.9 g/dL (slightly below reference range)
  • Hematocrit: 39.2%
  • Platelets: 193 ×10³/µL

Interpretation

The anemia showed marked improvement.

Compared with October 2021:

  • Hemoglobin increased from 10.4 → 12.9 g/dL
  • Hematocrit increased from 30.7% → 39.2%
  • RBC count returned to the normal range.

Although hemoglobin remained just below the laboratory reference range, the overall hematologic recovery was substantial.

Iron Studies

Results

  • Iron: 118 µg/dL
  • TIBC: 313 µg/dL
  • Iron Saturation: 38%
  • Ferritin: 43 ng/mL

Interpretation

Iron stores and iron availability were normal. These findings argue against iron deficiency as the primary explanation for the preceding anemia and support the conclusion that the anemia was more consistent with inflammation than with iron deficiency.

Autoimmune Evaluation

Anti-dsDNA Antibody

Result

  • 3 IU/mL (Negative)

Complement Levels

  • C3: 104 mg/dL
  • C4: 25 mg/dL

Interpretation

Anti-dsDNA antibodies remained negative, and complement levels were within normal limits. These findings did not provide evidence of active lupus-related immune complex disease at the time of testing.

Urinalysis

Results

The urinalysis was entirely normal.

Findings included:

  • No protein
  • No blood
  • No glucose
  • No ketones
  • No bacteria
  • No casts
  • No white blood cells
  • No red blood cells

Interpretation

The absence of proteinuria, hematuria, or urinary casts provided reassuring evidence that the kidneys were not showing laboratory signs of inflammatory or autoimmune involvement.

Overall Interpretation

This report documents substantial recovery from the severe inflammatory illness that dominated late 2021. The normalization of ESR and CRP demonstrates that active systemic inflammation had largely resolved. Blood counts improved dramatically, with recovery from inflammatory anemia. Iron studies were normal, supporting the conclusion that the anemia was inflammatory rather than iron-deficient. Autoimmune testing remained negative, complement levels were normal, and urinalysis showed no evidence of kidney involvement. Overall, this report represents one of the clearest laboratory indicators that recovery was well underway.

Longitudinal Significance

This report contributes to:

  • ESR Trend Table
  • CRP Trend Table
  • Hematology Trend Table
  • Iron Studies Trend Table
  • Autoimmune Evaluation
  • Kidney Monitoring
  • Systemic Inflammatory Illness Timeline
  • Rheumatology Consultation Summary
  • Medical History Timeline

It documents the transition from active inflammatory disease to measurable laboratory recovery.

Clinical Importance

⭐⭐⭐⭐⭐ Major Recovery Milestone

This report is one of the most encouraging studies in the Laboratory Library. It objectively demonstrates that the severe inflammatory process documented in August through October 2021 had largely resolved by mid-December, with corresponding improvement in anemia and normalization of inflammatory markers.

Key Changes Since Previous Report

Compared with the October 2021 evaluation:

  • ESR improved from 73 → 15 mm/hr.
  • CRP improved from 35 → 2 mg/L.
  • Hemoglobin improved from 10.4 → 12.9 g/dL.
  • RBC count returned to the normal range.
  • Hematocrit improved from 30.7% → 39.2%.
  • Iron studies demonstrated adequate iron stores.
  • Anti-dsDNA antibodies remained negative.
  • Complement C3 and C4 remained normal.
  • Urinalysis showed no evidence of renal involvement.

Related Reports

  • August 31, 2021 – Initial Systemic Inflammatory Evaluation
  • September 7, 2021 – Inflammation Monitoring Evaluation
  • October 13, 2021 – Peak Systemic Inflammatory Illness Evaluation
  • ESR Trend Table
  • CRP Trend Table
  • Hematology Trend Table
  • Autoimmune Evaluation
  • Rheumatology Consultation Summary
  • Medical History Timeline

Navigation

  • Previous Report: October 13, 2021 – Peak Systemic Inflammatory Illness Evaluation
  • Next Report: 2022 Rheumatology Follow-up Evaluation
  • Return to Laboratory Library
  • Return to Health Inventory

Observation

This report represents one of the great turning points in your Health Inventory. The October 2021 studies documented severe systemic inflammation, progressive anemia, and significant illness. Two months later, this report tells a very different story:

  • The inflammatory markers returned to normal.
  • The anemia improved dramatically.
  • Iron studies showed that iron deficiency was not the cause of the anemia.
  • Autoimmune markers remained reassuring.
  • Urinalysis confirmed that your kidneys had not been affected by the inflammatory process.

When viewed alongside the earlier reports, this study marks the beginning of your recovery phase and provides objective laboratory evidence that the disease process had become substantially less active.